AAIC 2025 Abstract·23 DecPharmacokinetic characterization of buntanetap in plasma of patients with early Alzheimer’s and Parkinson’s diseasesTrial in peopleInterventionsPaper
AAIC 2025 Abstract·23 DecA dual 6‐month (stage 1) & 18‐month (stage 2) prospective, randomized, placebo‐controlled, double‐blind, pivotal clinical trial investigating efficacy and safety of buntanetap in early Alzheimer's patientsTrial in peopleInterventionsPaper
AAIC 2025 Abstract·23 DecAdvancing Buntanetap: Comparative Pharmacokinetic Characterization of the Original Semi‐Crystalline with the Novel Crystalline Form in Animals and HumansTrial in peopleInterventionsPaper
AAIC 2025 Abstract·23 DecDesign of Phase III study testing buntanetap efficacy in early Alzheimer's patients based on the insights from previous studiesTrial in peopleInterventionsPaper